Related Experiment Videos
The rationale for operative therapy of symptomatic single-vessel coronary artery disease
Insights
Coronary artery bypass grafting (CABG) offers significant benefits for patients with symptomatic single-vessel disease, showing high survival and symptom relief rates. This suggests single-vessel disease may be a distinct condition, not part of a broader continuum.
Area of Science:
- Cardiology
- Cardiac Surgery
- Vascular Medicine
Background:
- Symptomatic single-vessel coronary artery disease (CAD) presents unique challenges in treatment.
- Understanding the long-term outcomes of surgical intervention is crucial for patient management.
Purpose of the Study:
- To evaluate the efficacy and long-term outcomes of coronary artery bypass grafting (CABG) in patients with symptomatic single-vessel disease.
- To investigate whether single-vessel CAD represents a distinct entity rather than a stage in a disease continuum.
Main Methods:
- Retrospective analysis of 184 patients undergoing CABG for symptomatic single-vessel disease over an 8-year period.
- Assessment of operative mortality, late cardiac death, symptom status (angina), and myocardial infarction (MI) rates.
- Follow-up catheterization to evaluate ventricular function.
Main Results:
- No operative deaths and a 5-year cumulative survival rate of 97.9% (only one late cardiac death).
- At 48 months mean follow-up, 91% of patients were angina-free or reported improvement.
- Low incidence of perioperative and late myocardial infarction (MI) and preserved ventricular function.
Conclusions:
- Coronary artery bypass grafting (CABG) provides significant, durable benefits for severely symptomatic patients with single-vessel disease.
- The findings support the hypothesis that single-vessel coronary artery disease may be a unique manifestation of atherosclerosis.
- This challenges the traditional view of single-vessel disease as merely an early stage in a progressive continuum.
Abstract:
During an 8 year interval, 184 patients with symptomatic single-vessel disease underwent coronary artery bypass grafting (CABG). There were no operative deaths and only one late cardiac death (5 year cumulative survival 97.9%). At 48 months mean follow-up, 91% are angina free or improved. The low incidence of perioperative and late myocardial infarction (MI) and the preservation of ventricular function seen on follow-up catheterization suggest that coronary bypass operations yield significant benefits in severely symptomatic patients with single-vessel disease. Evidence is presented which supports the idea that single-vessel coronary artery disease may be a unique manifestation of coronary atherosclerosis and not one stage in a continuum.